SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-24-020697
Filing Date
2024-12-16
Accepted
2024-12-16 19:43:49
Documents
2
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 6058
2 POA exhibit24-1.htm EX-24.1 481550
  Complete submission text file 0001062993-24-020697.txt   489403
Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PALVELLA THERAPEUTICS 125 STRAFFORD DRIVE WAYNE PA 19087
Business Address
Kaupinen Wes (Reporting) CIK: 0001918142 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 241553290